It is important to note that SIRT3 and its inhibitors are a promising new avenue to explore the development of therapies for other oral diseases, such as head and neck cancer, by inhibiting cell proliferation and promoting apoptosis [30]. Here, SIRT3 is linked to head and neck cancer.